NEW YORK--(BUSINESS WIRE)--MultiPlan Corporation (“MultiPlan” or the “Company”) (NYSE: MPLN), a leading provider of technology and data solutions that improve affordability, quality and transparency ...
NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.
LAGUNA HILLS, Calif., March 25, 2021 /PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early stage breast cancer, announced today that it ...
SAN DIEGO, June 15, 2021 /PRNewswire/ -- Prometheus Laboratories, Inc. ("Prometheus"), a leader in precision healthcare, announces the execution of an agreement with MultiPlan, a trusted partner to ...
NEW YORK, July 12, 2020 /PRNewswire/ -- Churchill Capital Corp III ("Churchill") (NYSE: CCXX), a public investment vehicle, and MultiPlan, Inc. ("MultiPlan"), a market-leading, technology-enabled ...
IRVINE, Calif., March 04, 2021 (GLOBE NEWSWIRE) -- Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points ...
Franklin, Tenn.-based Community Health Systems is the latest health system to sue MultiPlan over allegations the data analytics firm conspired with major payers to underpay providers by tens of ...
RUTHERFORD, N.J.--(BUSINESS WIRE)-- Cancer Genetics, Inc. (OTCQB: CGIX) ("CGI" or the "Company"), a leader in oncology-focused personalized medicine, has entered into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback